blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2509942

EP2509942 - BIS-ACYLATED HYDROXYLAMINE DERIVATIVES [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  01.03.2019
Database last updated on 15.05.2024
FormerExamination is in progress
Status updated on  14.11.2016
Most recent event   Tooltip01.03.2019Refusal of applicationpublished on 03.04.2019  [2019/14]
Applicant(s)For all designated states
Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218 / US
For all designated states
Cardioxyl Pharmaceuticals Inc.
Exchange East, Suite 212 1450 Raleigh Road
Chapel Hill, NC 27571 / US
[2012/42]
Inventor(s)01 / TOSCANO, John P.
18 Tree Farm Court
Glen Arm Maryland 21057 / US
02 / SUTTON, Art
627 West 34th Street Apt. A4
Baltimore Maryland 21218 / US
03 / KALISH, Vincent J.
344 Dubois Road
Annapolis Maryland 21401 / US
04 / BROOKFIELD, Frederick Arthur
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
05 / COURTNEY, Stephen Martin
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
06 / FROST, Lisa Marie
114 Milton Park
Abingdon Oxfordshire OX14 4SA / GB
 [2012/42]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2012/42]Wright, Simon Mark
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date10795136.007.12.2010
WO2010US59331
Priority number, dateUS20090267399P07.12.2009         Original published format: US 267399 P
US20090291224P30.12.2009         Original published format: US 291224 P
[2012/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011071947
Date:16.06.2011
Language:EN
[2011/24]
Type: A2 Application without search report 
No.:EP2509942
Date:17.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2011 takes the place of the publication of the European patent application.
[2012/42]
Search report(s)International search report - published on:EP29.03.2012
ClassificationIPC:C07C311/48, C07C233/92, C07C233/66, A61K31/67, A61K31/18, A61P9/04
[2012/42]
CPC:
C07D333/34 (EP,US); A61P35/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07C233/01 (US); C07C233/64 (US); C07C259/06 (EP,US);
C07C259/10 (EP,US); C07C271/08 (EP,US); C07C311/51 (EP,US);
C07C311/53 (EP,US); C07C317/14 (EP,US); C07C317/28 (US);
C07C317/32 (US); C07D207/16 (EP,US); C07D213/40 (EP,US);
C07D213/71 (EP,US); C07D295/205 (EP,US); C07D295/215 (EP,US);
C07D307/82 (EP,US); C07D309/12 (EP,US); C07C2601/08 (EP,US);
C07C2601/14 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/42]
TitleGerman:BIS-ACYLIERTE HYDROXYLAMINDERIVATE[2012/42]
English:BIS-ACYLATED HYDROXYLAMINE DERIVATIVES[2012/42]
French:DÉRIVÉS D'HYDROXYLAMINE BIS-ACYLÉE[2012/42]
Entry into regional phase15.06.2012National basic fee paid 
15.06.2012Designation fee(s) paid 
15.06.2012Examination fee paid 
Examination procedure15.06.2012Examination requested  [2012/42]
04.02.2013Amendment by applicant (claims and/or description)
07.11.2013Despatch of a communication from the examining division (Time limit: M06)
19.05.2014Reply to a communication from the examining division
07.04.2016Despatch of a communication from the examining division (Time limit: M06)
15.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
20.01.2017Reply to a communication from the examining division
17.09.2018Cancellation of oral proceeding that was planned for 18.09.2018
18.09.2018Date of oral proceedings (cancelled)
13.11.2018Despatch of communication that the application is refused, reason: substantive examination [2019/14]
23.11.2018Application refused, date of legal effect [2019/14]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.11.2013
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.01.2017Request for further processing filed
20.01.2017Full payment received (date of receipt of payment)
Request granted
03.02.2017Decision despatched
Fees paidRenewal fee
11.12.2012Renewal fee patent year 03
12.12.2013Renewal fee patent year 04
11.12.2014Renewal fee patent year 05
10.12.2015Renewal fee patent year 06
13.12.2016Renewal fee patent year 07
12.12.2017Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.12.201809   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]DE1768511  (BASF AG) [X] 1,3-5,8,9,12,13 * page 9, lines 3-4 *;
 [X]US3948967  (KRENZER JOHN, et al) [X] 1,3 * example 5 *;
 [X]US4405357  (CHANG JUN HSIN [US]) [X] 1,7-11,16,17 * examples 13-15,37-39,41-43,45-47,51-53,56,62-65 *;
 [X]US5977146  (MUELLER BERND [DE], et al) [X] 1,6,8-10,16 * column 124, lines 36-45 *;
 [Y]  - LEE M J C ET AL, "PRODRUGS OF NITROXYL AS INHIBITORS OF ALDEHYDE DEHYDROGENASE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19920101), vol. 35, doi:10.1021/JM00098A008, ISSN 0022-2623, pages 3648 - 3652, XP002056135 [Y] 1,3-13,16,17,19-32 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00098a008
 [Y]  - KLAUS REHSE AND CO, "Hydroxylamine Derivatives", ARCHIV DER PHARMAZIE, (19980424), vol. 331, pages 365 - 367, XP002660162 [Y] 1,3-13,16,17,19-32 * compounds 4,8,12 * * the whole document *
 [X]  - LEE JEEWOO ET AL, "Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N'-(4-(methylsulfonylamino)benzyl)thiou rea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, (20040503), vol. 14, no. 9, doi:10.1016/J.BMCL.2004.02.002, ISSN 0960-894X, pages 2291 - 2297, XP002445723 [X] 1,7-10,16 * compounds 20,21 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2004.02.002
 [X]  - OTTO NEUNHOEFFER AND CO, JUSTUS LIEBIGS ANNALEN DER CHEMIE, (19700129), vol. 736, pages 100 - 109, XP002660163 [X] 1,3-5,7-10 * compound 5 *
 [X]  - BYEONG HYO KIM ET AL, "INDIUM MEDIATED REDUCTIVE ACYLATIONS OF NITROARENES TOWARDS N,O-DIACYLATED N-ARYLHYDROXYLAMINES", SYNTHETIC COMMUNICATIONS, TAYLOR & FRANCIS GROUP, PHILADELPHIA, PA, (20010101), vol. 31, no. 23, ISSN 0039-7911, pages 3577 - 3586, XP009152508 [X] 1,3-6,8-11,16,17 * entries 5-10;; table 3; compound 5 *
 [X]  - TOMAZIC A ET AL, "SYNTHESES OF SOME AZINYLHYDROXYLAMINES (1)", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, (19790701), vol. 16, no. 5, doi:10.1002/JHET.5570160507, ISSN 0022-152X, pages 861 - 864, XP002021611 [X] 1,6,8-11,16,17 * compound 7 *

DOI:   http://dx.doi.org/10.1002/jhet.5570160507
 [X]  - YAGODINA O V AND CO, CHEMISTRY OF HETEROCYCLIC COMPOUNDS, (19880609), vol. 25, pages 908 - 913, XP002660164 [X] 1,6,8-11,16,17 * compounds IVa, Va *
 [X]  - LOUIS F. FIESER ET AL, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (19400701), vol. 62, no. 7, doi:10.1021/ja01864a002, ISSN 0002-7863, pages 1640 - 1645, XP055007919 [X] 20 * compound V *

DOI:   http://dx.doi.org/10.1021/ja01864a002
 [X]  - MILEWSKA, "Oxidation of Amino Acids. IV* Reaction of Dibenzoyl Peroxide with w-Amino Acid Esters", AUSTRALIAN JOURNAL OF CHEMISTRY, CSIRO, AU, (19870101), vol. 40, no. 11, ISSN 0004-9425, pages 1919 - 1922, XP009152501 [X] 1,10,11,16,17 * compounds 3a-d *
 [X]  - STANLEY C. BELL ET AL, "A new synthesis of 7-chloro-1,3-dihydro-5-phenyl-2 H -1,4-benzodiazepin-2-one 4-oxide", JOURNAL OF HETEROCYCLIC CHEMISTRY, (19671201), vol. 4, no. 4, doi:10.1002/jhet.5570040435, ISSN 0022-152X, pages 647 - 649, XP055008133 [X] 1,10,11,16,17 * compound X *

DOI:   http://dx.doi.org/10.1002/jhet.5570040435
 [X]  - JYH MING LIN ET AL, "An investigation of the intramolecular ene reaction of N-acyl imines", THE JOURNAL OF ORGANIC CHEMISTRY, (19860101), vol. 51, no. 2, doi:10.1021/jo00352a008, ISSN 0022-3263, pages 167 - 174, XP055008134 [X] 1,10,11,16,17 * left column; page 171 - lines 2-3 * * compound 23 *

DOI:   http://dx.doi.org/10.1021/jo00352a008
 [X]  - PEDRO P O SANTOS AND CO, TETRAHEDRON LETTERS, (19930323), vol. 34, pages 3793 - 3796, XP002660165 [X] 1,3-5,8-10,16,17 * entries 2,4,7,11,13,14; page 3794; compound 6 *
 [X]  - DAVID J. ANDERSON ET AL, "Novel synthesis of pyrido[1,2- a ]benzimidazoles via reaction of N -acyl arylhydroxylamines with pyridine", JOURNAL OF HETEROCYCLIC CHEMISTRY, (19860701), vol. 23, no. 4, doi:10.1002/jhet.5570230426, ISSN 0022-152X, pages 1091 - 1094, XP055008200 [X] 1,3-5,10,11,16,17 * compound 11 *

DOI:   http://dx.doi.org/10.1002/jhet.5570230426
 [X]  - BERNARD LOEV ET AL, "Bis-N,O-diacetylhydroxylamine analog of diaminodiphenyl sulfone possessing antimalarial activity", JOURNAL OF MEDICINAL CHEMISTRY, (19730201), vol. 16, no. 2, doi:10.1021/jm00260a018, ISSN 0022-2623, pages 161 - 163, XP055008192 [X] 1,3-5,8,10,11,16,17,21 * compound TAHDS *

DOI:   http://dx.doi.org/10.1021/jm00260a018
 [X]  - SMITH D G ET AL, "The Inhibition of Human Cytomegalovirus (hCMV) Protease by Hydroxylamine Derivatives", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, (19991101), vol. 9, no. 21, doi:10.1016/S0960-894X(99)00539-9, ISSN 0960-894X, pages 3137 - 3142, XP004181022 [X] 1,3-5,10,11,16,17,21 * compound A9 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(99)00539-9
 [X]  - BASKAKOV AND CO, BIOLOGICHESKI AKTIVNYKH SOEDINENII, (19680101), vol. 71, pages 98 - 100, XP009152640 [X] 1,3-5,8-13,16,17 * page 99; table 2; compounds XX-XXIII, XXVIII *
ExaminationWO03020221
 WO2007109175
 WO2009137717
by applicantUS4369174
 US4663351
 US4798824
 US4842866
 US5217720
 WO03020221
 US6569457
 US6638534
 US2004038947
 WO2005074598
 US6936639
 WO2007002444
 US2007006710
 WO2007109175
 WO2007120839
 US2007299107
 US2009163487
 WO2009137717
    - LOWES ET AL., CLIN. CARDIOL., (2000), vol. 23, no. III, pages 1 - 6
    - BOUZAMONDO ET AL., FUNDAM. CLIN. PHARMACOL., (2001), vol. 15, pages 95 - 109
    - BRISTOW ET AL., J. CARD. FAIL., (2001), no. 7, pages 8 - 12
    - HART ET AL., AM. J. PHYSIOL. HEART CIRC. PHYSIOL., (2001), vol. 281, pages 146 - 54
    - HARE ET AL., CIRCULATION, (1995), vol. 92, pages 2198 - 2203
    - MA ET AL., PROC. NAT'LACAD. SCI., (1999), vol. 96, no. 25, pages 14617 - 14622
    - TAKAHIRA ET AL., FREE RADICAL BIOLOGY & MEDICINE, (2001), vol. 31, no. 6, pages 809 - 815
    - STOYANOVSKY, D.A. ET AL., J. MED. CHEM., (2004), vol. 47, pages 210 - 217
    - SIROVICH, I. ET AL., TUMOR BIOL., (1999), vol. 20, pages 270 - 276
    - NORRIS A. J. ET AL., INTL. J. CANCER, (2008), vol. 122, pages 1905 - 1910
    - BONNER, F.T. ET AL., INORG. CHEM., (1992), vol. 31, pages 2514 - 2519
    - ZAMORA, R. ET AL., BIOCHEM. J., (1995), vol. 312, pages 333 - 339
    - SHA, X. ET AL., J. AM. CHEM. SOC., (2006), vol. 128, pages 9687 - 9692
    - REHSE ET AL., ARCH. PHARM. MED. CHEM., (1998), vol. 331, pages 104 - 110
    - THEVIS ET AL., BIOMED. CHROMATOGR., (2001), vol. 15, pages 393 - 402
    - TNGALL, POSTGRAD. MED., (2000), vol. 107, no. 6, pages 34 - 50
    - SLOTWINER-NIE ET AL., GASTRNENTEROL. CLIN. N. AM., (2001), vol. 30, no. 3, pages 625 - 635
    - H.T. NAGASAWA ET AL., J. MED. CHEM., (1992), vol. 35, pages 3648 - 3652
    - CARPINO ET AL., J. AM. CHEM. SOC., (1959), pages 955 - 957
    - CARPINO ET AL., I. AM. CHEM. SOC., (1959), pages 955 - 957
    - BIOORG. MED. CHEM., (2002), pages 639 - 656
    - JOURNAL OF PHARMACY AND PHARMACOLOGY, (1963), pages 202 - 211
    - BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (1996), vol. 6, pages 2651 - 2656
    - TETRAHEDRON, (1994), pages 5049 - 5066
    - FUKUTO, J.M. ET AL., CHEM. RES. TOXICOL., (2005), vol. 18, pages 790 - 801
    - MINCIONE, F. ET AL., J. ENZYME INHIBITION, (1998), vol. 13, pages 267 - 284
    - SCOZZAFAVA, A. ET AL., J. MED. CHEM., (2000), vol. 43, pages 3677 - 3687
    - CRAWFORD, J.H. ET AL., BLOOD, (2006), vol. 107, pages 566 - 575
    - GAO W.D. ET AL., CIRC. RES., (1995), vol. 76, pages 1036 - 1048
    - NORRIS A. J. ET AL., INTI. J. CANCER, (2008), vol. 122, pages 1905 - 1910
    - KATORI, T. ET AL., CIRC. RES., (2005), vol. 96, pages 234 - 243
    - RASTALDO ET AL., AM. J. PHYSIOL., (2001), vol. 280, pages H2823 - H2832
    - PAOLOCCI ET AL., AM. J. PHYSIOL., (2000), vol. 279, pages H1982 - H1988
    - HARE ET AL., J. CLIN. INVEST., (1998), vol. 101, pages 1424 - 31
    - MA ET AL., PROC. NATL. ACAD. SCI., (1999), vol. 96, pages 14617 - 14622
 US20030463084
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.